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Abstract.  We report the complete sequence of the 
microtubule-associated protein MAP1B, deduced from 
a  series of overlapping genomic and cDNA clones. 
The encoded protein has a predicted molecular mass 
of 255,534 D  and contains two unusual sequences. 
The first is a highly basic region that includes multiple 
copies of a  short motif of the form KKEE or KKF_~ 
that are repeated, but not at exact intervals.  The sec- 
ond is a  set of 12 imperfect repeats, each of 15 amino 
acids and each spaced by two amino acids.  Subcloned 
fragments spanning these two distinctive regions were 
expressed as labeled polypeptides by translation  in a 
cell-free system in vitro. These polypeptides were 
tested for their ability to copurify with unlabeled brain 
microtubules through  successive cycles of polymeriza- 
tion and depolymerization.  The peptide corresponding 
to the region containing the KKEE and KKE~ motifs 
cycled with brain microtubules, whereas the peptide 
corresponding to the set of 12 imperfect repeats did 
not.  To define the microtubule binding domain in vivo, 
full-length and deletion constructs encoding MAP1B 
were assembled and introduced into cultured cells by 
transfection.  The expression of transfected polypep- 
tides was monitored by indirect immunofluorescence 
using anti-MAP1B-specific antisera.  These experi- 
ments showed that the basic region containing the 
KKEE and KKF_~ motifs is responsible for the interac- 
tion between MAP1B and microtubules in vivo. This 
region bears no sequence relationship to the microtu- 
bule binding domains of kinesin,  MAP2, or tau. 
M 
ICROTUBULES prepared in vitro by successive cy- 
cles of assembly and disassembly consist largely 
of a- and/3-tubulin,  together with a  number of 
other proteins that are collectively defined as microtubule- 
associated proteins (MAPs)  ~ (for reviews,  see 32, 35, 52). 
Because neuronal  cells are rich in microtubules,  the best 
characterized  MAPs are those from brain.  Conventionally, 
these MAPs have been classified according  to their molecu- 
lar mass: the high molecular mass MAPs, MAFIA, MAPIB, 
MAFIC, and MAP2 (in the range 200-350 kD), and the low 
molecular mass  MAPs,  or tau proteins,  a  heterogeneous 
group of proteins in the range  35--40 kD (51). MAP3 and 
MAP4 are less abundant than these; MAP3 is primarily ex- 
pressed in astroglia  and some neurons (21), while MAP4 is 
expressed in glia, vascular, and some other tissues (37). With 
the exception of MAP1C, which has been identified as cyto- 
plasmic dynein (38, 49) the function of brain MAPs is essen- 
tially unknown, though  many have been shown to promote 
microtuhule assembly upon addition  to purified  tubulin in 
vitro. 
Among  the  high  molecular  mass  MAPs,  MAP1B  (7) 
(which is referred to variously as MAP1.2  [16], MAPI(X) 
[9],and MAP5 [40]) differs from the others in its high abun- 
dance, its prominence both in association with microtubules 
1. Abbreviation  used in this paper:  MAP, microtubule-associated protein. 
and in soluble form, and the relative inefficiency with which 
it cycles  with tubulin,  particularly  during  the first  cycle. 
Nonetheless,  MAP1B is generally regarded  as an authentic 
MAP because it does cocycle with purified tubulin and pro- 
mote microtubule assembly in vitro (40) and because an- 
tisera specific for MAP1B (both polyclonal and monoclonal) 
identify  characteristic  microtubule  networks  in  neuronal 
(and other) cells (6,  12). MAP1B is expressed in the axons 
and dendrites  of neurons,  as well as in glia and other cells. 
Because it is especially prominent in axons during their ini- 
tial outgrowth  (40, 43), it has been suggested that MAP1B 
plays a role in neurogenesis. 
Several years ago, we isolated a set of cDNA clones encod- 
ing a portion of a MAP1 subspecies (28).  Subsequently,  an 
antiserum (3d2) raised against a fusion protein derived from 
one of  these clones was shown to uniquely recognize MAPIB 
on Western blots of brain microtubules and of total protein 
from PC12 cells (1). The same antiserum also gives a staining 
pattern  identical  to that  of other anti-MAPlB antisera  on 
brain sections (A. Matus and N. J. Cowan, unpublished ob- 
servations),  thereby proving that our original  set of cDNA 
clones were derived from MAFIB mRNAs. We have now ob- 
tained  two genomic clones and further overlapping  cDNA 
clones that together encode the entirety of MAPIB. Here we 
report the complete sequence of MAP1B, deduced from these 
clones. The encoded protein has a molecular mass of 255, 
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12 imperfect repeats that do not occur in any other sequenced 
protein, each  15 amino acids long, and spaced by 2 amino 
acids. The other is a highly basic region with many copies 
of the sequence KKEE and KK~, repeated but not at fixed 
intervals. We show that it is this latter region which is respon- 
sible for the binding of MAPlB to micrombules both in vitro 
and in vivo. 
Materials and Methods 
cDNA and Genomic Clones 
eDNA from 5-d-old mouse brain mRNA was prepared as described (26), 
except that half was ligated to Eco RI linkers (Boehringer Mannheim Bio- 
chemicals, Inc., Indianapolis, IN) and half to Xba I linkers, and each por- 
tion cloned into the vector ~Gem (Promega Biotec,  Madison, WI). The 
resulting libraries were screened (4) as described in the text, using purified 
eDNA restriction fragments 32p-labeled by nick translation (41). Hybridiz- 
ing clones were subeloned into pUC,  restriction-mapped, and,  in some 
cases, sequenced.  Sequencing of the complete set of overlapping clones on 
both strands was  accomplished by subeloning bal31-generated  fragments 
(27) into M13, and using the dideoxy  chain terminator method (42). Four 
overlapping genomic clones containing the 5' end of the MAPlB gene were 
obtained by screening a  mouse genomic library in the EMBIA vector, 
ldndiy provided by P. WEustachio (New York Medical Center). The cosmid 
clone C (Fig. 1), including the 6-kb MAPIB exon, was isolated by screening 
a library (provided by S. Tonegawa, Massachusetts Institute of Technology) 
with done 141A (Fig.  1). 
Constructs for Translation, Fusion Proteins, and 
Transfection Experiments 
Two constructs encompassing repeated  sequences were made for in vitro 
transcription, translation, and cycling experiments as follows: (a) clone 72 
was digested with Xho I, blunt-ended with the Klenow fragment of DNA 
polymerase I, cut with Bgl II, and the coding fragment (Fig.  1, 5' arrow) 
cloned into the transcription vector pGEM3 (Promega Biotec) cut with Hinc 
II and Barn HI; (b) clone 141A was digested with Pst I and Eco RI, and the 
purified fragment (Fig.  1, 3' arrow) cloned into pGEM3 cut with the same 
restriction enzymes.  For both constructs, an in-frame translational start sig- 
nal was provided by the pGEM vector.  The insert from the first of these 
pGem clones, including the initiator AUG, was cloned into a pSV vector (34) 
for expression in cultured cells (Fig. 1, construct X). In addition, constructs 
were made from the 5' and 3' end of the set of MAPIB cDNAs to place the 
translational start and stop signals: (a) the insert from clone 12X was sub- 
cloned into the Xba I site of pGEM1; and (b) the Sac I/Eco RI fragment 
was cloned into pGEM3 cut with Arc I, blunt ended with Klenow and then 
digested with Eco RI; this procedure supplied an AUG codon for transla- 
tional initiation in frame with the MAPIB coding S~luence. 
The full coding sequence of MAPIB was assembled, first by joining 
clones 12X and IR at an internal Ptim I site, then by digesting the resulting 
construct with Xho I and F,  co RI, and finally by adding both the Xho I/Ssp 
I fragment from cosmid clone C and the Ssp I/F,  co RI fragment from clone 
166 in a three-way ligation. The clones and cloning sites are depicted in Fig. 
1. The full cloning region was subcloned into a pSV vector using a unique 
Sal I site in the 5' flanking pUC polylinker,  and a unique Dra I site in the 
3' untranslated region. Deleted versions were obtained by (a) joining a Msc 
I site to a Pvu I site blunt ended with I"4 DNA polymerase (Fig.  1, 1B-H); 
(b) deleting an '~l-kb Msc I fragment by self-ligating a gel purified fragment 
from a partial Msc I digest (Fig.  1, 1B-K); and (c) by joining the Xho I and 
Bg ]1 sites, by blunt ending each with the Klenow fragment of DNA poly- 
merase I  (Fig,  1,  1B-X). 
To raise an antiserum specific for the second set of repeats, a Pst I/Eco 
RI fragment (Fig. 1, 3' arrow) from clone 141A was subcloned into a pATH 
vector (29) that was used to express a fusion protein whose amino terminal 
part is Escherichia coil TrpE, and whose carboxyterminal part is derived 
from MAPIB.  Fusion protein excised from SDS polyacrylamide  gels was 
used to immunize rabbits. The resulting serum is called YXY; its specificity 
is demonstrated in Fig.  7. 
Transcription, Translation, and Microtubule 
Cycling Experiments 
pGEM subclones were linearized at the 3' end and transcribed in vitro using 
SP6 polymerase as described (33). The capped mRNAs were translated in 
rabbit  reticulocyte  lysate  (Promnga  Biotec)  supplemented  with  either 
[35S]methionine or [3H]lysine. Translation products were resolved on SDS 
polyacrylamide gels, which were fluorographed,  dried, and exposed to film. 
Micmtubule cycling experiments were performed as described (30). 
Hybrid Selection and Primer Extension 
Clone 5X (Fig.  I) was used to select MAPIB-specific  mRNA from total 
mouse brain RNA (100#gm/2.l-cm nitrocellulose  filter)  by methods  de- 
scribed previously  (17). The selected RNA was used in a primer extension 
reaction  containing an  antisense oligonucleotide,  5'CCTGAGAGAAGT- 
GTTCCTY (corresponding to nucleotides  17-34 of the sequence  shown in 
Fig.  4),  32p-end labeled with polynucleotide  kinase.  Reaction  conditions 
and analysis of the extended  product were as described (3). 
Transfection Experiments and Immunofluorescence 
Hela cells were  grown in DME supplemented with 5%  FCS (Hydone 
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Figure I. MAP1B clones and con- 
structs. The top line is a compos- 
ite  map  of  our  set  of  MAP1B 
clones. The hatched and open rec- 
tangles represent regions encoding 
the KKEE/KKE~ repeated motifs 
and  the  15-amino  acid  repeats, 
respectively (see Fig. 4). The start 
codon (v) and stop codon (v) are 
indicated, as are some salient re- 
striction sites: P, Pvu I; Pf, Pltm 
I; M, Msu I; X, Xho I; B, Bgt H; 
S, Ssp I; D, Dra I. The arrows in- 
dicate fragments subcloned for in 
vitro cycling experiments, and for 
the  generation  of  antisera  3d2 
(1) and YXY  (see Materials and 
Methods). Thin lines show the ex- 
tent of eDNA and genomie clones which span the coding region of MAP1B. Clones with names ending in X came from an Xba I-linkered 
eDNA library, while those with names ending in R  came from an Eco RI-linkered eDNA library (see Materials and Methods).  Other 
clones have been previously described (28). Deletion constructs created for transfection experiments are indicated by heavy lines, and the 
results of these experiments are shown at the right:  +,  microtubule binding;  -,  no mierotubule binding. 
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under the same conditions, except 10% FCS was used. Cells growing on 
glass coverslips were transfeeted with DNA by the procedure of Chen and 
Okayama (10),  and after 72 h fixed in one of three ways:  (a) with parafor- 
maidehyde (36); (b) with cold methanol for 6 min; or (c) with cold methanol 
following detergent extraction with 0.2%  Triton X-100  in a  microtubule 
stabilizing buffer (47). lmmunofluorescence was performed using one of  the 
twe rabbit anti-MAPIB antisera, 3d2 (1) or YXY (this paper). The regions 
of MAPIB to which these sera bind are shown in Fig. 1. A mouse anti-c~- 
tubulin  monoclonal antibody (Amersham Corp.,  Arlington Heights,  IL) 
was used for double labeling; FITC-conjugated goat anti-rabbit and rhoda- 
mine conjugated goat anti-mouse second antibodies were from Boehringer 
Mannheim Biochemicals. All antibodies were used at a dilution of 1:500. 
Results and Discussion 
Isolation of Clones Encoding MAP1B 
With a view to elucidating the structural and functional do- 
mains of MAP1B and its relationship to other MAPs, we first 
sequenced our original set of overlapping MAP1B-encoding 
cDNA clones.  This analysis showed that the set of clones 
contains a long open reading frame of 5.4 kb, extending from 
the 5' end of the overlapping set to a location 1.5 kb from the 
3' end. Because this open reading frame encodes a polypep- 
tide of at most ,~198,000 D, we extended our collection of 
overlapping cloned cDNAs  in  the  5' direction by further 
"walking" experiments. To facilitate the search for overlap- 
ping clones, we constructed two mouse brain libraries using 
different linkers for cloning. These were first screened with 
a small fragment from the 5' end of our 5' most overlapped 
cDNAs (clone 72; reference 28), and twice more, each time 
with fragments obtained from the new set of clones. Repre- 
sentative  examples  from  the  complete  set  of overlapped 
cDNA clones are depicted in Fig.  1. 
Figure 3.  The  MAP1B transcriptional 
initiation  site  lies  35  nucleotides  up- 
stream from sequences represented by 
overlapping cloned cDNAs. A synthetic 
antisense oligonucleotide corresponding 
to  nucleotides  17-34 of the  sequence 
shown in Fig. 4  was end-labeled with 
polynucleotide  kinase  and  used  in  a 
primer extension reaction with RNA hy- 
brid selected with clone 5X (Fig. 1) (see 
Materials and  Methods).  The reaction 
products were analyzed on a 6% poly- 
acrylamide  sequencing  gel.  Lane  1, 
selected RNA; lane 2, control (E.  coli 
tRNA); lane 3, molecular size markers 
(shown, in nucleotides,  right). 
Figure 2. Determining the placement of the start and stop codons 
within the MAP1B transcript. Fragments from the 5' and 3' end of 
our MAPIB  cDNA set  were  cloned  into  transcription  vectors; 
capped RNA was synthesized and translated in a cell free system 
containing  [35S]methionine (see  Materials  and  Methods).  The 
resulting labeled translation products were resolved on an 8.5 % 
SDS polyacrylamide gel. Lane 1, no RNA control; lane 2, RNA 
from clone 12X (nucleotides 1-1,574); lane 3, RNA from clone 137, 
linearized with Eco RI (Fig. 4, nucleotide 6,304-3' end of clone); 
lane 4, RNA from clone 137 linearized with Kpn I (Fig. 4, nucleo- 
tides 6,303-7,333); lane 5, RNA from clone 137 linearized with 
Nae I (Fig. 4, nucleotides 6,303-7,454). In lanes 3-5, the slowest 
migrating species results from initiation at an AUG triplet provided 
by the vector (see Materials and Methods),  whereas the second 
prominent band presumably results from initiation at an internal 
AUG codon. 
All attempts to extend this cloned set further in the 5' direc- 
tion  resulted  in  the  isolation  of numerous  unrelated  and 
nonoverlapping sequences that were presumed to be cloning 
artifacts generated by the unavoidable adventitious ligation 
of unrelated cDNA  sequences during construction of the 
cDNA library, or by "hairpinning" of cDNA generated dur- 
ing the synthesis of the second strand. Sequence analysis of 
the overlapping 5' cDNA clones extended the long open read- 
ing frame to 7.5  kb.  However, because this open reading 
frame  extended to  the  extreme 5' end  of our overlapped 
cDNAs, we cannot be certain whether the first AUG triplet 
indeed encodes the initiator methionine residue; it is possi- 
ble  that  further  upstream  sequences  encoding  additional 
aminoterminal MAP1B residues might be unrepresented in 
our cDNA libraries. However, we did three further experi- 
ments  which  strongly  suggest  that  translation  of MAP1B 
does  begin  at  the  first  AUG  triplet  found  in  our  cDNA 
clones. Firstly, a fragment extending from the extreme 5' end 
of the overlapped cDNAs (Fig.  1) was cloned into a vector 
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II  &  T  ] 
8 CGTGGTGGT GGAAGCCACCGAACCGGAG  ¢ CA*T  CGGG C  AGCA  T ¢GGC&ACCCGG¢GGCGT  120 
V  V  V  E  A  T  E  P  E  P  ~  G  S  I  G  N  P  A  A  B  23 
C C&C  CTCGCC  ¢AGCCTGT CGSACCGCT T C  CTAGAC~GCA&GT TCT&CTTGCTGGTGGTGG  11~ 
T  S  P  8  b  S  H  R  F  L  0  8  K  F  Y  L  L  V  V  V  ~3 
T CGGCGAGACCGTAA¢CGAAGAGCACCTGAGGCGTGC¢AT  CGGCAACAT CGAGCTGGSGA  260 
11  Ir  T  V  T  [  E  H  b  R  8  A  l  8  N  |  E  L.  G  |  63 
T CCGATGGTGGEACACAAACCTGAT TGAIiT GCAACT  TGEACC&GGAACT CA&ACT  TTT C8  800 
R  B  H  8  T  N  L  l  E  C  N  b  D  Q  E  b  K  L  F  V  88 
T AT C T¢GACACT 8TGCAAGATT CT CT¢CTGAAGTT 88AGGASAAAAGAT TCTT CAT CA¢8  3k8 
0  R  H  8  A  R  F  I;  P  E  V  •  Ii  Q  K  X  L  H  H  R  IO8 
GAAGTGACGT  CT  TAGAAACAIIT ¢GT  T CTGAT  ¢A&CC  CT  T CA~ATG&AI;C 0t;T CAG¢ACTG  620 
S  8  V  L  E  T  V  V  L  |  N  P  8  0  E  A  V  0  T  E  123 
AGGTGCGTT TGATGATCACTGACGCTGCCCGCCATAAACTGCTGGTGCT ¢ACCGGA¢&GT  480 
V  R  b  N  I  T  8  A  A  R  H  K  L  L  V  L  T  G  Q  C  143 
GCTTTGAGAACACTGSCGASCTSATCCTGCAGTCT88818TTTCTCCTTC(;&G&ASTTSA  840 
F  E  N  T  8  E  L  i  b  Q  ~  G  8  F  8  F  g  N  F  1  163 
TASAGATTTTSACAr-AT CAAOASATTGOTSASCTCSTAAOCACSASCSACCCTGCCAAS&  608 
E  ~  F  T  0  Q  E  1  0  [  L  L  8  T  T  H  P  A  N  K  t83 
AAGCCAGC CT CACSCTCTT8  TGT CCCGAGGAGGOAOACTGGAAGAAC  T C¢AACCTTGACA  660 
A  8  L  T  L  ~  C  P  [  E  G  0  W  K  N  ~  N  L  0  R  203 
G~CACAAT ¢T CCAAGACTI"CAT  CAA¢ATTAAGCTCAACTCAGCT  T ¢TAT CTTGCSAEAAA  720 
H  N  L  Q  D  F  I  N  i  K  L  N  8  A  S  I  L  P  [  H  223 
TOGAGOGACTTTCTGAOTTCASCSA~TATCTCTCAOAOT CTGTAOAASTC~CCTCTCCCT  780 
E  G  L  8  E  F  T  E  Y  L  E  E  8  V  E  V  P  8  P  F  243 
TTOA¢ATCCT80AACSCSCAACCTCGEGC08CTTTCTSAAGCT CTCCA&GCCTTGCTSTT  848 
D  I  L  8  P  P  T  8  8  8  F  L  K  L  8  K  P  C  C  V  263 
ACAT T T T CCCAOOOF'OCCGTGGGGACTCGGCCCTGTT  TOCAETGAACG&A¥ TCAACATG¢  900 
I  F  P  0  6  R  6  0  S  6  l  F  A  V  N  G  ~  N  ~  L  203 
T CAT  CAACGGAGG&T CAEAGAG&AAGT 8TTGCTTSTGKAAGCTCATCCGGC&CT TGGACC  960 
1  N  G  G  ~  E  R  K  0  C  ~'  I~  K  L  1  R  H  L  0  R  303 
GTGTGGACT  CCATCCTGCTCACCCAC6TTGGG8ATGACAATTTGCCTGGGAT 8AATAGCA  1820 
V  O  8  %  L  L  T  H  1  G  D  D  N  L  P  8  l  N  8  M  323 
TG C  TG¢AGCGC AASAT  T 8CASAGCTGGAAGAGGA8888T CSCAGSGGT C  (~AC  CAGC&AC&  1080 
L  g  R  K  1  A  E  L  8  8  E  R  8  Q  G  S  T  8  N  8  343 
GTGACTGGATSAAAAACC TCAT CT CSCCTGACC  TSGGGGTTGTGT  T T C T ¢~ACET ACCTG  1160 
D  #  H  K  N  L  l  8  P  D  L  G  V  V  F  L  N  V  P  E  363 
AAAACCTGAAAGACCCAGAACCCAACATCAASATEAAGAGAA~CATAGAAGAAGCATECT  1200 
N  L  K  0  ~  E  P  N  1  K  M  K  R  8  1  E  E  A  C  F  3~3 
T CACTCTC¢AGTACTTAAACAAACTGT¢CATGAAACCAG&GCCTCTATT  TAGAAGTI;TAG  126D 
T  L  g  V  L  N  K  L  8  fl  K  P  E  P  L  F  R  8  V  8  403 
8CAACACCATTGAGCCTGTCATCCTGTTCSAG&ASAT88GAGT8080AASCTTEASATST  1320 
N  T  ~  E  P  V  I  L  F  Q  K  FI  8  V  0  K  L  E  M  Y  62~ 
ACGTSCTTAACCCASTCAAAAGSAGSA&GGAAATGCAGTATTTTATGCAASAGTSGACTG  1380 
V  L  N  P  V  K  0  S  K  E  H  0  Y  F  Iq  0  Q  M  T  G  463 
~CACCAACAAAGACA6GOCCGAACTAATCCTGCCSAATGIIT CAA~AA~*T#,~ACATC CCGA  1440 
T  N  K  0  K  A  E  L  I  L  P  N  •  Q  E  V  O  1  P  I  463 
T TT CCTACT TAACCTCASTCTCATCTTTGATTGTGTGGCATCC88CCAACCCSGCTGAGA  t~OO 
5  Y  L  T  8  V  8  B  L  1  V  W  fl  P  A  N  P  A  E  K  483 
AAATCATT ¢GGGTT CTKT TTSC CG~AAACAGTACCSAST&CAACATCCTAGAAGGACTGG  1560 
1  I  R  V  L  F  P  6  N  8  T  Q  V  N  I  L  E  G  L  E  503 
AGAAACTCAAACATSTASATTT  CCTA&AGCAGCSA¢TGGC CACCC&AAAAG&TCTCACTO  1620 
K  L  K  H  L  O  ¥  L  K  g  P  L  A  T  Q  K  D  L  T  G  523 
OCCA~GTSCCCACCC  CC CCAETGAAACAOGT  CAAACT~AAACAGCGGGC TG&CAGC CGA~  1600 
0  V  P  T  P  P  V  X  Q  V  X  L  K  Q  R  A  0  8  R  E  043 
AGAGT CTTAAG8 CAGCCACEAAAC  CAGTTGCCAGTAAAT CT8,T~AGE*AA~6A~T CCAA~8  1740 
8  L  K  P  A  T  K  P  V  A  5  K  8  V  R  K  8  5  K  E  563 
AEGAAACCCCTSAAGT CACAAAGACTASTCAAGTGGAOAAAACAC¢CAAASTTEAAAGCA  1800 
8  T  P  8  V  T  K  T  8  g  V  E  K  T  P  K  V  E  S  K  583 
AASAG4AAGTGTTAGTGAAAAAAGASAAGC CTGTAAAGACAGAAAGTAAAC CTTCAGTGA  1860 
8  K  V  L  V  K  K  D  K  P  V  K  T  E  8  K  P  8  V  T  603 
CASAAAAEGAGSTGT CCAOCAAS~AAEAGCAGTC  CC CAG TGAAAGOCSA~GT CGC TGAGA  1920 
8  K  E  V  S  S  K  8  E  Q  5  P  V  K  A  E  V  A  8  X  023 
AGSAAGCCACTSAGAGCAAACCCAAAGTCAC  CAAGS&CAAA~TGOTAAAAAAGSAAAT AA  t980 
0  A  T  E  8  K  P  K  V  T  K  0  K  V  V  K  K  F..  I  H  643 
AGACAAAACT 8GAGGAAAAGAAAGAGGAGAAG¢CCA&GAAAGAASTGKT TAAOAAGOAAE  2040 
T  K  L  8  E  K  K  E  8  K  P  K  K  E  V  V  K  K  8  0  663 
ACAAAACACCCCTCAASAAAGACEAGAASCCAAEAAAGSAASAGOTGAAi~AAGEAGAT  CA  2100 
K  T  P  L  K  K  0  8  K  P  R  K  E  E  V  K  K  E  I  K  683 
AGAAAGAAAT CAAAAAAEAAGAGAGAAAGGAGCTGAAGAAAEAGGTGAAGAA06AAA CA C  2160 
E  1  K  K  E  E  R  K  E  L  K  K  E  V  K  K  E  T  P  703 
CCSTG6AGGATGCCAAOAAGGAGGTG6AGAAAGAOGAOAAGAAAG&AGT  ¥6AAAAOGAAG  2220 
L  K  0  A  K  H  E  V  K  K  E  E  K  K  [  V  K  K  E  E  723 
AOAA0~AA8 C  CAAAAAGOAAA  T CAASAA(;ATCT C  CA6GOA CAT  AAAGAAAT CAA  CTC  C  T C  2280 
K  8  P  K  K  E  1  K  K  1  S  K  D  1  K  K  8  T  P  Q  7~3 
A,~TCAGACACAAA(~AASCCAT  CTGCST T6AAAC ¢AAAAGTAOCGAAOAAAOAAGAOT CCA  23¢0 
S  D  T  K  K  P  8  A  L  K  P  K  V  6  K  K  E  E  8  T  763 
CTAAGAASGAOCCT CT TSCTOCTSG86A6CT CAA88ACAA888'~AAAGTC6AAOTCATTA  2400 
K  K  E,,,,,,  P  L  A  A  G  K  L  K  D  K  G  K  V  K  V  !  K  783 
A~AASGAASGCAA~AC CACASAAG866CTSCCACAGCTOTTGGCACTGCTSC  CACCACAO  24b0 
K  E  G  K  T  T  E  A  A  A  T  A  V  G  T  A  A  T  T  A  803 
¢ T,~¢ C81GGT 0GCT O080¢ 101388T A8 ¢EGC CAOT 0~T CCT  0 T CAAAI;AAC TEOAAOCT~  2520 
A  V  V  A  A  A  0  1  A  A  0  G  P  V  K  E  L  E  A  E  823 
AGAGGT¢C¢IIATGTCCTCCCCTGAGGATCTAAC¢AAGG&CTTTGAGGAG¢TAAAGGCT6  2080 
R|LRBSPEOLTKOFEELKAE  863 
AGGAGATTGATETGGC¢AAGGACATCAAGC¢TCAG¢TGGAECT¢&TTGAAGATEAAG&GA  2840 
E40VAKO|KPQLEL|EOEEK  163 
AACTGAAG6AAACCCAGCCGGGAGAAGCCTACGTCATCCAGAAAGAGAC&G&AGTCAGCA  2700 
LKETGPGEAYV|QK[T[VSK883 
AAGGTTCCGCTGAGT¢A¢CCGATGAGGGAATCACCACCACCGAGGGGGAGGGCEAGTETG  2780 
GEAESPDEGITTTEEEGECE  903 
AGCAAACCCCTGAGGAGCTGGAGCCAGTTGAGA&GCAGGGCGTGGATGACATTGAGAAG¥  2820 
GTPEELEPVEKGGVDO1EKF923 
TTGAAGATGAAGGAGCTGGTTTTGAAGAATCCTCAGAGAC¢GGAGACTA¢GAAGAGAAGG  2880 
EDEEAGFEEgSETGDYEEKA9&8 
CGGAAACTGAGGAGGCTGAGGAACCGGAAGAGG&CGGGGAAG~CAATGCGAGCGGGAGTG  29~O 
ETEEAEEPEEDEEONASGSA963 
CCTCTAAGCACAGCC¢¢ACAGAAGATGACGAAAGCGCAAAGGCTGAGGCGGA¢GTGCACC  3000 
BKHSPTEDOESAKAEADVHL  983 
e 
TCA&GGAGAAGAGGGAGTCTGTGGTC&GTGGTGACGACCGGGCGGAAGAAGACATGG&TG  3060 
KEKRESVVSGOORAEEDRDOlOO3 
ATGTGCTTEAGAAAGGAGAAGCTGAACAGTCTGAEGAAGAGGGCGAAGAGGAGGAC&AAG  3t20 
VL£KGEAEgSEEEGEEEDKAt023 
CAGAGGATGCCAGAGAGGAAGGCTATGAGCCCGACAAAACTGAGGCTGAGG&TTATGTGA  3180 
EOAREETY[PDKTEAEOYVM1043 
TGGC¢GTGGCTGACAAGGCGGCTGAGGCTGEAGTCACAGAGGAGCAGTACGGATACCTGG  32¢0 
AVAOKAAEAGVTEEGYGYLGI0b~ 
8CA¢GTCGGCCAAGC&ACCTGGAATCCAGTCTCCTAGCCGAG&ACCTGCATCTTCAATTC  3300 
TSAKgpE|gSPSREPASSIH1083 
ATGATEAGACCCTACCTGGAGGCTCTGAGAGCGAGGCCACTGCTTCGGATGAGGAGAATA  3360 
OETLPGGSESEATASDEENRl103 
GGEAAGACCA6CCTGA~OAATTCA¢TGCTACCTCTGEATATACTCAGTCTACCATTGA¢A  3620 
[DOPEEFTATSG¥TGST|El~123 
TATCTAGTGAGCCTACGCCAATGGATGAG&TSTCTACTCCTCGTGATGTGATGAGCGACG  3480 
~  SEPTFHO[MSTPRDVRSOEll¢3 
AGA¢CAACAACGAGEAGACAGAGTCCC¢ATCTCAGGAGTTCGTAAACATTACCAAATATG  ]5¢0 
TNNEETESP[Q[FVN|TKYEtt68 
AGTCCTCGCTGTATTCTCAGGAGTA¢TCCAAACCTGCTGT¥GCATCATTCAATGGATTGT  ]&00 
58LYS~EYSKPAVABFNGLS1183 
CAGAAG66TCAAAAACASACGCCACTSATGGTAA68ATTACAASGCTTCCGCCTCCACCA  3660 
[GSKTOATOGKDYNASAST|1203 
TATCACCACCTTCGTCCATGGAAGAAGAC6AATTCAGCA6GTCTGCTCTTCGTGATGCT~  3720 
5PPS~MEEO~FSHSALRO6Y1223 
ACTSCTCAGAASAGAAAGAGTTGAAAG¢CAGTGCCGAGTTAGACATCAAAGATSTTTCA8  3780 
CSEEKELKASAELDIKDV501283 
ATGAGAGACTTAGCCC&SCCAASASTSCATCCCTGAGTSCTTCTCCGCCATCCCCCATAG  ~880 
ERLSPAKSPSLSPSPPSPIE1263 
AEAAGACTCCCCTGGGTGAA88TAGCGTSAATTTCTSTSTSACACCC&ATGAGATTAAAE  3900 
KTPLOERSVNFSLTPNE|KV1283 
TGTCA0CAGAGOGAOAAGCAASGTCAGTOTCCCCTGOA~TGACCCAOGCAOT&OTTGAAE  3960 
8AE68ARSVSPOVT~AVV88130~ 
AACATTOTOCCAGTCCTGASGAG&ASACCCTGGAAGTASTSTCGCC&TCCCASTCTSTG6  ~020 
HCASPSEKTLEVVSPOQSVTl~23 
CA080AOTGCTSGCCACACACCTTACTACCAATCTC¢CACCGATGAGAASTC¢AGTCACC  4080 
08AOHTPYY~SPTOSKOSHLl~43 
TACCCACA06AOTCAOTGAAAACSCACASGCAOTTCCAGT~A~CTTTSAATTCASTSA88  ¢1&0 
PTEVSSNAQAVPVSFSF80A1363 
CCAAAGATGAOAACGAGAGAOCOTCCCTAAGCCCCATG6ATGAOCCTGTGCCTGACTCA6  4280 
HD[NERASLSPHOEPVPO881383 
AGTCTCCTGTGGAGAAGGTTCTGTCTCCTTTACGCAGTCCTCCCCTTCTTGGATCTOAGT  4~60 
8PV[KV~SPLRSPPLL08881803 
CCCCATATOAASACTTCCTSAOTOCTOATASCAAGGTTCTTSGCAOAC~TTCCOAAAGCC  4~20 
PYEDFLSADSKVLSRRSESP~¢23 
CCTTTGAAGGGAAGAATGGAAAGCA88GCTTCCCAOACAGAGAAAGCCCAGTTTCTGACC  ¢380 
FE~KNOK~GFPDREOPVS~Ll¢43 
TSACTTCCACT80TCTTTACCAAOASAAACAGOAAGAGAAAA~CACGGGCTTCATACCCA  4440 
TSTGLY~OKQEEHSTG¥IPII683 
TAAAGOAAGACTTTSGTCCAGAAAAOAAAACCA~T~AT~TTGAAACCAT~AGTTCTCAAT  4800 
KSDFOPSKKTSDVSTRSSQS~¢&3 
CAOCTCTAGCTTT8GATGAAAGOAAATTOOSAOOAOATSTATCTCCAACACAAATASAC8  4~60 
ALALOSRKLGOOVSPTOIDVI~03 
TCAGTCAOTTT880TCTTTCAAASAAOACA¢CAASATSTCCATTTCAGAASGCACTSTIT  ¢620 
08FGSFKEOTK~SISEOTV~1523 
CAGACAAGTCAOCCAC&CCTGTGGATSAGGGTGT00CAGAAGACACCTACTCCCACATS~  ~600 
DKSATPVD[OVAEOTYOHfl[IS¢~ 
AOG~TGTGOCCTCCGTCTCTACTGCC]C101~OCTACAA~TTCOTTTCCAOAOCCAACCA  ~740 
5VASVSTASVA188FPEPTT~S&3 
CAGATOAC6TGTCTCCTTCTCTGCATOCCG&OGTGGGTTCTCCACATTCCACAGAA~TT~  ~800 
00VSPSLHAEVSSPHSTSV~l~83 
ATGACTCCCTGTCCSTTTCTGTGGTGCAAACACCTACCACGTTCCAGGAAACAGAAATGT  ¢8~0 
DSLOVSVVQTPTTFSETEMSi603 
CTCCATCTAAAOAAGA~TSCCCAAOACCGATSTCAATTTCTCCTCCAGACTTCTCCCCCA  ~20 
PSK800PRP~8]~PPDFOPK~623 
AGACAGCCAAATCCAGGACACCAGTTCAAO&TCACCGATCTOA&CAGTCTTCTATGTCTA  4980 
TA~ORTPV~OHR88~SSHSIl~¢3 
TTOASTTCGGCCA00AATCCCCTSAGC~TTCTTTTOCTATOGACTTTA~TC~CA~TCTC  ~O&O 
8FS~ESPSHSFARDFSR~PI6~3 
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0  H  P  T  L  G  A  S  V  L  H  I  T  E  N  G  P  T  (  V  1683 
TEGA¢TATA61"CCCT6TI3ATAT CCA6GAC T CTAGT T T6TCGCATAAGAT CCC6CCAAC6E  5160 
D  Y  8  P  C  D  l  g  0  S  8  L  8  H  K  1  P  P  T  E  1708 
e 
AAGA6CCAT  CCTACACC  CAG6AT AA T6A T C 76 T C T  6AGCT CA T C T CT 676T C'f CAEGTA&  6220 
E  P  S  Y  T  Q  0  t4  0  L  8  E  L  I  ~i  V  8  Q  V  E  t723 
AGGC T T CC CC6T CCACCTCTT  CAGCT CACACCCCT  TCT CAGATAGCC 1C T C¢ I CT T C666  S~80 
A  8  P  S  T  5  S  A  H  T  P  5  Q  l  A  8  P  L  O  E  17~3 
AA6ACACT CT ¢ TCTSATST TGT TCCTC¢CAGASAGATf~TCC TTATATGCC TCACT T 6C6 T  TJ360 
0  T  L  8  0  v  V  P  P  R  E  PI  8  L  Y  A  S  L  A  5  1763 
CTGAAAAAGTSCASAGCCTGGAAGGA6A6AA6C TCTCT CCGAAATCT 661 AT1TCT C  CAC  5~,00 
E  K  V  g  S  L  E  6  E  K  L  S  P  ~  S  O  I  S  0  L  1783 
TCACCCCAC6ATA6TCCTCACCTTTATATTCACCTGGCTT  TTCA6A t TCTACC~ CT6CA6  5 ~,.60 
T  P  It  E  8  8  P  L  Y  S  P  G  F  5  0  S  T  S  A  A  1~S03 
CTAAA6AGAC  T 6¢AGCAGCT CAC CAAGC C  T C C  T CT T CC  C CAC CAAT 66676CA6CA#, CA6  55~0 
K  E  T  A  A  4  H  Q  6  5  S  S  P  P  l  0  6  A  i"  A  1823 
CAGAGCCC TATGGCTT CCSCTCCT CAA16CTATT TGATACAATGCAACAT CAI CT65CCT  5550 
E  P  Y  6  F  R  S  8  N  L  F  O  1"  N  Q  H  H  L  A  L  18~3 
TGAATAGA6ATT TEA CTACATC  T661GT66A6AAASACAGCGSA666AAGACACCCI~,A6  5660 
N  R  D  L  T  T  S  8  V  E  K  D  $  G  6  g  T  P  ~  D  1863 
ACT T T AAC TAT6CC TA T¢AAAAG¢¢ T6A6AA T6C  C6CCG6AT C TCCAGAT~AA6AA6A ~ 1  5700 
~F  #  ¥  A  Y  g  g  P  E  ~  6  A  6  ~  P  O  E  E  0  Y  1~3 
AT6AC TAT6AAT CT CAA6AGAAAACCATCC66ACCCA¢6ACGT  6~TGC6T ; ACTACTA$  G  5760 
0  Y  E  S  g  E  K  T  1  R  T  H  0  V  V  R  V  _V..Y  E  t~'o3 
AGAAGACAGAGAGAACCATAAAAT CCCCAT6TEACASTG667ACT ¢CTATEAEAC CAT 75  5820 
~_r._t  2  ~  ,  K  s  ~  c  o  8  ~  ,  .:_~  E  "~  t  ~  ~23 
A6AAGACCACCAA6ACCCCA6AA6AT6GT66C TACACCT6TGAAATTACCGA6AAAAC  CA  $880 
~_~__~._X__~_~E_O_  6  ~  ¥  ~  c  t  z  T  E  K  r  r  ~963 
C T CEGAC C C  C6666666(~0 T 6 G  C T A T T CA T  A T 6AEA T C  At~  CGAGAA.",:~ACGA  C6C  617,A  C  C  C  $960 
R  T  P  ~  E  6  G  Y  8  *~lr"  ~  |  8  E  K  T  T  R  1"  P  ~963 
CT6661,~T666C666 TACAC  CTAT6AAAA6ACT6A6A66TCCA6AA(;GCTCCT6~AT~A¢A  6000 
EE_V  8  t3  Y  T  Y  E  K  T  E  8  S  R  R  L  L  0  D  1  ';983 
T TA6CAATGGCTATGAT~ACACT6AEGATGGCEGCCACACACT  T5666ACTSTA6CTACT  6060 
8  N  G  Y  D  O  .~  E  O  6  6  H  T  L  5  0  C  S  V  8  2008 
CCTATGAAACCACTGAGAAAAT TACCA6CT TT CCTEA6T CTGAAAGCTATT CCTACGAEA  6120 
V  E  T  T  E  K  %  T  8  F  P  [  5  E  5  Y  8  Y  E  i"  2023 
CAA6TACAAAAACAACACGGA6  T C CAEA CA CCT  C  T6CAT ACT  G  T TA C6AGACCA'[ 6~666  6'~80 
$  T  K  t  T  R  8  P  0  T  S  A  Y  C  V  E  T  FI  E  g  2043 
AGAT CACCAAGACCC CAGAGGCAT CCACATACT  CC T ATGA6ACCTCAGAC  C6AT6C TACA  6260 
z  T  ~  T  e  O  A  6  T  v  s  v  ~  T  s  o  ~  c  v  T  2063 
(~  TA¢G6AAAA6AAGY CC  C  C  C  TCASAGGCACGC CAEGAT  6TTGAT  T  1  AT  6T  C  T6GT6T  C  C  T  b300 
T  E  g  K  S  P  8  E  A  R  g  0  V  0  L  C  L  V  S  8  2083 
CCTGTEAATTCAA6CATCCCAAGAC66A6CTCTCGCCTTCCTTCATY~ATCCAAATCCTC  b360 
CEFKHPKTELSPEFINPNPL2t03 
TTEAGTGETTTGCTGET6AA6A6CCCACTGAASAATCAGASAA6CCCCTCACTCAETCT6  6620 
EU~AGEEPTEESEKPLTQSG2123 
6A6GAECCCCCCCACCTTCA66A66AAAA¢&ACAG66CA66CAAT6C6ATGAAACGCCAC  6680 
6APPPSG6KQQERgCOETPP2t63 
C¢ACCTCAETCAETGA6TCAGC¢CCATCCCAEACA6ACTCTGATGTTCCCCCAEAEAC66  8540 
TGVSESAPSQTDSDVPPETE2t63 
AAGAETECCCCTCCATCACAGCCEACGCCAATATTGACTCT6AASATEAGTCASAAACTA  6600 
ECPSITAOANIOBSDESETI2tB3 
TCCCCACAEACAAAACC6TCACATACAAACACATS6A¢CCACCTCCAGCCCCCAT6¢AAG  6660 
PTDKTVTVKHMOPPPAPRQ02203 
ACCGAA6CC¢TT¢TCCTC6CCACCCC6A¢676TCCAT66T66ACCCAGAC6CCTTGG¢A6  6720 
R~PSPRHPOVSHVOPDALAV2223 
TT6A¥CAGAACCTA66CAA86C¥ETGAAAAAAGACCTEAAEGA6666&CCAA6AC¢AAGA  6780 
8~NL6gAVHKDLHEKTKTKK2263 
A6CCAGECA¢AAAGACCAAETCCTCTTC&CCTGTCAAAAASGGTSAT6~SAAGTCCAAGC  6540 
P6TKTKgSSPVKKGOGKSKP2~63 
CTTTASCAGCTTCCCCCAAA¢CA66AGCTTTGAAG6AATCCTCCGACAAGTT6TCCAGA6  6900 
LAASPKP~ALKESSDKVSRV2283 
TGGCTTCTCCCAAGAAGAAAGAATCC6T66AAAAAGCTACAAAGACCACCACCACTCC¥6  6960 
ASPKKKEgV~KATKTTTTPE2303 
AE6TCAAAECCACACGC66CGAAGA6AAG6ACAA6666ACCAAGAA¢GCAGCTAAC6CCT  7020 
VKATRE££KDKETNNAANA82323 
CT~CATCCAAATCASCGAAGACCGCAACGACAGGACCAGTAACCACTAA~ACAGCCAAST  7080 
ASKSAKTATT6PGTTKTAK52363 
CGTCCAC¢6TGCCTCCAG6CCTCCCTG$6TATTT66A¢CT6T6CTATATTCCCAACCACA  ?~60 
STVPPGLPVYLOLCYIPNHS2363 
6CAACAGTAAGAATGTCGATETTGAGTTCTTCAAEAGAET6A66TCATCTT~CTACGT66"  7200 
NSKNVDVEFFKRVRSSYYVV2883 
T6AET66GAACGACCCtTC¢6CEEA66AGCCCAGCC668CTGTCCTG6ATGCCTTGTTGG  7260 
86NOPAAEEPSRAVLOALLE2603 
AA865AAGECTCA6TGGGEAASCAACATSCAGGTGACTC]GATTCCGACACATGACTCCG  7320 
6KAgMGSNROVTL|P~HOSE2623 
A6ET~ATEAGEGA6TG6TACCAGGAGACCCACGAGAAGCASCAEGAC¢TCAACATCATG5  7380 
VHREMYOETHEKQODLN1MV26~3 
TCTTAGCAA6CA6CAETACAET66TCAT6CAAGA¢6A6TCCTTCCCC6CATGCAAGATAG  7640 
LASSBTVVHgOESFP&CKIE2663 
AACTGT66A6ACC6CAGCC66CCACACCACA66ATTTGAACTGTTTTTCCAGAAATTCTT  7500 
L  t  2666 
6AATTT6AAACTAC¢TTTTCTAAAA¢6TCCATTCATCCAATTAA6TCACTSAACAGTTAT  7560 
TA¢CT6CCA~AT6CTATACTAT6TCAT66T~ATGCAAGTCA¢TGATA~TTCTCAATTTTT  7620 
Figure 4. Complete sequence of MAP1B. The nucleotide sequence of our set of overlapping cDNA clones is shown together with the encoded 
amino acid sequence, in the one letter code. (The sequence of 1.4 kb of 3' untranslated region is not shown, but the entire sequence has 
been submitted to GenBank.) A repeated basic motif encoded toward the 5' end is underlined; a second set of repeats near the 3' end is 
indicated with dashed underlines. Possible phosphorylation sites for casein kinase II are indicated in two ways: predicted (e) and strongly 
predicted (*) (see text). 
designed for in vitro transcription. Capped mRNA synthe- 
sized from this construct was translated in a cell-free system 
containing [35S]methionine, and the reaction products were 
analyzed by SDS-PAGE. The data from this experiment (Fig. 
2) show an abundant translation product whose molecular 
size is consistent with initiation at the first AUG within the 
long open reading frame.  Therefore,  the 5' proximal AUG 
functions as an efficient translational initiator in vitro. The 
same AUG is also capable of efficient translational initiation 
in vivo (see below). Secondly, to examine the possible exis- 
tence  of  MAP1B-encoding  aminoterminal  sequences  up- 
stream from the region covered by our overlapping cDNAs, 
we  isolated  a  corresponding cloned genomic  fragment by 
screening a mouse genomic  library with a MAP1B cDNA 
probe. An antisense synthetic oligonucleotide corresponding 
to  sequences  close  to  the  5'  end  of overlapped  MAP1B- 
encoding cDNAs was then used as a sequencing primer to 
determine  upstream  genomic  sequences.  This  experiment 
showed that while the reading frame specified by the MAP1B 
amino acid sequence remains open, there are no potential 
upstream AUG codons; however, there is a canonical TATA 
sequence that could potentially form part of the promotor for 
the MAP1B gene (data not shown). Thirdly, we performed 
a primer extension experiment using an antisense oligonu- 
cleotide corresponding to nucleotides 17-34 of our MAP1B 
cDNA sequence (see below) and RNA isolated (from total 
mouse brain RNA) by hybrid selection with clone 5X (Fig. 
1). The result of this experiment is shown in Fig.  3: an ex- 
tended  product  69  nucleotides  in  length  appears  in  the 
primed reaction containing selected RNA that is not present 
in a control reaction containing an equivalent mass of tRNA. 
Because the 5' end of the primer used in this experiment is 
located at nucleotide 34 in the sequence determined  from 
overlapping  cloned  cDNAs,  this  experiment  locates  the 
MAP1B cap site only 35 nucleotides 5' to the beginning of 
the sequence shown in Fig. 4. Given the absence of upstream 
AUG codons in upstream genomic DNA and the very short 
5' sequence not represented in our cloned cDNAs, the likeli- 
hood of translational initiation occurring at a  site 5' to the 
first  AUG  present  in the long open reading  frame  of our 
cloned cDNAs seems  very remote. 
To confirm  the position of the translational termination 
codon, which our sequence analysis placed 1.5 kb from the 
3' end of our cDNA clones, a restriction fragment spanning 
the region containing the 3' end of the long open reading 
frame was cloned into a vector designed for the transcription 
of RNA sequences. An initiator methionine codon was sup- 
plied in frame with the cloned insert via the AUG contained 
in the polylinker of the pGEM vector. This construct was lin- 
earized at restriction sites that we predicted would be either 
Noble et aL MAPIB Microtubule Binding Domain  3371 YAYQKPENAAGSPDE 
YDYESQEKTIRTHDV 
YYYEKTERTIKSPCD 
YSYETIEKTTKTPED 
YTCEITEKTTRTPEE 
YSYEISEKTTRTPEV 
YTYEKTERSRRLLDD 
NGYDDTEDGGHTLGD 
YSYETTEKITSFPES 
YSYETSTKTTRSPDT 
YCYETMEKITKTPQA 
YSYETSDR~TAKSPSE 
CY  EK 
Figure 5.  12 imperfect repeats in 
the sequence of MAPIB. The re- 
peats indicated by dashed under- 
lines in Fig. 4 are aligned (A), and 
a  consensus  sequence  is  shown 
(B). 
before or  after the  putative  stop  codon.  These  linearized 
DNAs were then used as templates for in vitro mRNA syn- 
thesis,  and  the mRNA  was  translated in  vitro in  a  rabbit 
reticulocyte lysate containing [35S]methionine.  As shown in 
Fig. 2, only the template cut 5' to the predicted stop codon 
(at Kpn I) yields a truncated product, thus confirming the ex- 
istence of the stop codon at the position indicated in our 
MAP1B  eDNA clones. 
Because of the large size of MAP1B and the total absence 
of any protein sequence data, we checked the putative open 
reading frame in two ways, in addition to verifying the start 
and stop codons as described above. First, we verified that 
the reading frame in each of our original Xgtll expression 
clones matched the predicted long open reading frame. Sec- 
ond, we made seven E. coli-trpE fusion proteins with vari- 
ous fragments derived from the set of cDNAs in the reading 
frames predicted by our sequence data. In each case, the size 
of the fusion protein was in good agreement with that calcu- 
lated from our sequence data (data not shown). Two of these 
fusion proteins were used to raise antisera:  3d2  (reported 
previously [1]) and YXY (see Fig.  1). These two fusion pro- 
teins were chosen because of their unusual amino acid se- 
quences (see below). The sera generated using these fusion 
proteins are especially useful because they uniquely recog- 
nize two widely spaced and well defined regions of MAP1B. 
In particular,  they are in all probability not against phos- 
phorylated epitopes; antibodies to phosphorylated epitopes 
can  produce confusing results,  in  part  because the phos- 
phorylation of MAPIB is dependent on developmental stage 
(43), and also because some of these antibodies cross react 
with phosphorylated epitopes on the neurofilament and other 
proteins (2, 31). 
Deduced Sequence of  MAPIB 
The sequence of our overlapping MAP1B  cDNAs together 
with the deduced amino acid sequence of MAP1B is shown 
in Fig. 4.  The encoded protein is 2,463 amino acids long, 
with a molecular mass of 255,534 D. While this is smaller 
than its apparent size on SDS polyacrylamide gels, MAP1B 
(like tau, MAP2, and NF-M [18, 24, 25]) is known to run 
anomalously large in such gels (12).  The predicted size of 
MAP1B is, however, ,,025 % larger than the calculated size 
of MAP2, which is consistent with their relative mobilities. 
Two regions of repetitive amino acid sequence, each 'x,200 
residues long, are evident in Fig. 4. One is a highly basic re- 
gion containing many sequences of the form KKEX, where 
X is almost always an acidic or hydrophobic residue. These 
repeated motifs do not fall into any strict pattern, although 
they are clustered in the central part of a region containing 
many basic  amino  acids.  Indeed,  the  region from amino 
acids 589-787 has a calculated net charge of +30, and both 
the methods of  Chou-Fasman (11) and Gamier et al. (15) pre- 
dict that it folds into short, accessible hydrophilic c~-helices, 
although these predictions are notoriously unreliable (50). 
The second repetitive region of MAP1B spans amino acids 
1865-2070, and consists of 12 imperfect 15-amino acid-long 
repeats (Fig.  5);  each repeat is  separated by two noncon- 
served amino acids. This region is also quite hydrophilic, and 
is predicted to fall on a series of turns in the MAP1B  mol- 
ecule. 
Recently, it has been discovered that MAP2 and tau have 
a highly similar carboxyterminal domain that contains three 
(or four [19, 20]) 18-amino acid-long imperfect repeats (24, 
30). This domain has been shown to constitute the microtu- 
bule binding site of MAP2 and tau both in vitro (24, 30) and 
in vivo (S. A. Lewis, I. E. Ivanov, G. H. Lee, and N. J. Co- 
wan,  manuscript submitted for publication).  However, the 
repeats in MAP2 and tau have no similarity to either the ba- 
sic  repeated  motif of the  15-amino  acid-long  repeats  in 
MAP1B, nor are there any regions of significant sequence ho- 
mology between MAP1B  and either tau or MAP2. Indeed, 
when the deduced amino acid sequence of MAP1B is com- 
pared with the PIR protein data base, no significant homol- 
Figure 6. Translated protein corresponding to the first repeated mo- 
tif in MAP1B  cycles with microtubules in vitro. Capped RNAs tran- 
scribed from two regions (Fig. 1, arrows) were translated in a cell 
free system containing rH]lysine or [35S]methionine (see Mate- 
rials and Methods). Translation products were cycled  with microtu- 
bules, and at each stage, aliquots containing the same amount of 
protein (40 #gm) as judged by absorption at A2s0/A2~0 were ana- 
lyzed on a 14% SDS-polyacrylamide gel. Lane 1, 3H-labeled pro- 
tein derived from 5' subclone; lanes 2 and 3, 40 #g of microtubule 
protein after 1 and 2 additional cycles of assembly and disassembly 
in the presence of added 3H-labeled translation product. Lane 4, 
35S-labeled protein derived from the 3' subclone; lanes 5 and 6, 40 
#g of microtubule protein after 1 and 2 additional cycles of assem- 
bly and disassembly in the presence of added 3SS-labeled  transla- 
tion product. The times of exposure have been adjusted to compen- 
sate for the difference in specific activity between [3H]lysine and 
[35S]methionine in the cell-free system, the relative abundance of 
lysine and methionine residues in the respective peptides, and the 
relative fluorographic detection efficiency of the two isotopes. 
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domain of MAP1B encompassing the KKEE and KKE~ re- 
peated motifs shows some (probably fortuitous) sequence 
similarity to basic regions in other proteins, primarily to 
histones and other nuclear proteins but also to the highly 
charged tails of the neurofilament triplet proteins. This may 
account for the cross-reactivity of several anti-MAP1B anti- 
bodies with nuclear (12) or neurofilament (31) antigens. 
The phosphorylation of MAP1B increases during neurite 
outgrowth, both in PCI2 cells induced to differentiate with 
nerve growth factor (1, 5, 14) and in neuroblastoma cells that 
generate neurites when serum is removed from the growth 
medium (13). MAP1B is also found in phosphorylated form 
in developing axons in vivo (43). These facts, together with 
the elevated levels of MAP1B protein found in developing 
axons (or neurites) in vivo and in vitro (14,  16, 43), and the 
increased affinity of phosphorylated MAP1B  for microtu- 
bules (13), suggest that phosphorylated MAP1B plays a role 
in the cytoskeletal changes that accompany neurite exten- 
sion. A casein kinase II type activity is implicated in MAPIB 
and t/-tubulin phosphorylation both in brain and in cultured 
differentiating neuroblastoma cells (13, 46).  Casein kinase 
II phosphorylates serine and threonine residues in sequences 
of the form ~, ×  ~  where X #: K, R; however, only those se- 
quences that fall on/3 turns in a protein appear to be phos- 
phorylated  (39).  The  primary  recognition  sequence  for 
casein kinase H occurs 81 times in the MAP1B sequence; in 
30 cases these sequences are predicted to form/3 turns by the 
Chou-Fasman and Gamier algorithms, and, in seven of  these 
cases, turns are strongly predicted. These 30 potential phos- 
phorylation sites are indicated in Fig. 4; nine are clustered 
in the region of MAP1B containing the 12 imperfect repeats. 
The Microtubule Binding Domain of  MAPIB 
There exists within the MAP1B amino acid sequence two 
regions containing repeated motifs (discussed above). The 
fact that the microtubule binding regions of both MAP2 and 
tau contain repeated sequences (24, 30), and that microtu- 
bules are themselves composed of repeating subunits sug- 
gested that one of  these regions might constitute the microtu- 
bule binding domain. To test the ability of these domains to 
bind to microtubules, restriction fragments encoding regions 
spanning each set of repeats (Fig. 1, arrows) were subcloned 
into RNA transcription vectors; a translational start signal in 
the correct reading frame was in each case provided by the 
vectors. The resulting constructs were used as templates for 
the transcription of capped mRNA, and the transcription 
products used to direct protein synthesis in vitro in a rabbit 
reticulocyte lysate containing either [3H]lysine On the case 
of the first repeat region, which contains no methionine or 
cysteine residues) or [35S]methionine (in the case of the sec- 
ond repeat region). The translation products were added to 
two-cycle-purified, depolymerized bovine  brain  microtu- 
bules, which were then taken through two further cycles of 
polymerization and depolymerization. After each cycle, ali- 
quots containing the same amount (40 #gm) of protein were 
removed and analyzed by SDS-PAGE,  to see whether either 
labeled polypeptide could coassemble with the unlabeled 
carrier microtubules. The result of this experiment is shown 
in Fig. 6. A labeled polypeptide derived from the first repeat 
region was observed to cycle with brain microtubules, though 
there is a significant loss (of ",,60%) of labeled polypeptide 
with each successive cycle; in contrast, a labeled polypeptide 
derived from the second repeat region completely failed to 
cycle. The relative inefficiency with which the labeled poly- 
peptides from the first repeat region cycles with microtu- 
bules in vitro could result from competition with endogenous 
unlabeled MAP1B present in the microtubule preparations 
used in these experiments, or from the inherently poor cy- 
cling efficiency of MAP1B with microtubules in vitro (6), or 
a combination of both these factors. Nonetheless, these data 
suggest that the region containing the basic  repeated se- 
quence motifs is responsible for the cycling of MAP1B with 
microtubules during their purification. 
To determine whether this domain is also responsible for 
MAP1B-microtubule interactions in vivo, a  construct de- 
signed to express the entirety of MAP1B was made and trans- 
fected into cultured cells. To facilitate the assembly of a full- 
length MAP1B coding region, we isolated a mouse genomic 
clone from a cosmid library containing a 6-kb exon (Fig. 1, 
clone C). After  joining this exon to cDNAs derived from the 
5' and 3' ends of the MAP1B transcript, the full coding se- 
quence was inserted into a vector containing promotor and 
terminator sequences derived from SV40. The final construct 
was transfected into HeLa and 3T3 cells and the disposition 
of MAP1B in transfected cells was assayed by double label 
immunofluorescence, using either of the anti-MAP1B an- 
tisera 3d2 and YXY,  described above, and a  mouse anti- 
a-tubulin monoclonal antibody. The observed patterns of 
MAP1B staining were dependent on the fixation conditions: 
no MAPIB was observed bound to detergent extracted cyto- 
skeletal preparations, but in cells fixed directly in methanol 
(in which case proteins are fixed and extracted simultane- 
ously) MAP1B-decorated microtubules were observed (Fig. 
7,  a  and b).  Notably, in cells fixed directly with parafor- 
maldehyde, MAP1B filled the cytoplasm, obscuring the mi- 
crotubule-bound MAP1B (data not shown). This implies that 
much or most MAPIB in transfected cells is in soluble form. 
Thus, in contrast to MAP2 (S. A. Lewis, I. E. Ivanov, G.-H. 
Lee, and N. J.  Cowan, manuscript submitted for publica- 
tion), MAP1B binds to microtubules weakly, and the equilib- 
rium favors the unbound state since none remains bound to 
microtubules when the unbound portion is removed by deter- 
gent  extraction.  This  is  consistent  with  the  behavior  of 
MAP1B  in brain  (32),  and the poor  cycling efficiency of 
MAP1B with microtubules in vitro (7). 
This assay for the binding of MAPIB to microtubules in 
vivo allowed us to define the microtubule binding domain by 
making constructs expressing deleted forms of MAP1B, and 
transfecting them into cultured cells. The results of these ex- 
periments  are  summarized  in  Fig.  1;  representative  im- 
munofluorescence data are shown in Fig. 7. Deletion of the 
5' half of the MAPIB coding region (construct 1B-H) or of 
those sequences encoding amino acids 524-848 (construct 
1B-K) results in the expression of truncated forms of MAP1B 
that have completely lost the capacity to bind to microtubules 
(e.g., Fig. 7, c and d). Thus, the region of MAP1B containing 
the repeated KKEE and KKF_~ motifs is alone responsible 
for microtubule binding both in vitro and in vivo. 
Two further constructs, X and 1B-X (Fig. 1), show that the 
microtubule binding domain is divisible.  The protein ex- 
pressed from X includes only amino acids 646-732, whereas 
that expressed from IB-X contains all of MAP1B with the ex- 
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HeLa cells. After 72 h, cells were fixe~  with methanol, and analyzed by indirect double label immunofluoresence  using the YXY antibody 
(a and c) directed ~galnst  a segment of  MAP1B (see Fig. 1), and an anti-ot-tubulin  monoclonal  antibody (b and d). a and b, Cells tmnsfect~ 
with MAPIB; c and d, cells transfected with the IB-K  construct ffig. 1); untmnsfeeted cells in a are indicated by amm~. Bar, 10 #m. 
ception of this region.  Surprisingly, the protein expressed 
from  each  of  these  complementary  constructs  binds  to 
microtubules with approximately the same efficiency (within 
the limits of our assay) as intact MAP1B. This implies that 
at least two subregions from the KKEE and KKE[, -con- 
taining region bind independently to microtubules. It there- 
fore seems likely that MAP1B binds to at least two tubulin 
subunits in the polymer, and that this bridging of subunits is 
involved in nucleating microtubule polymerization and in 
stabilizing microtubules. 
Conclusions 
We have cloned and sequenced cDNAs spanning the entire 
coding region of the MAP1B gene, and shown that a basic 
region of  the MAP1B protein, containing many repeats of the 
form KKEE or KKFA, is the MAP1B-microtubule binding 
domain. This was accomplished experimentally in vitro by 
cycling translated fragments with microtubules, and in vivo, 
by transfecting constructs expressing full-length and deleted 
forms of MAP1B into cultured cells. The MAP1B binding 
domain is completely unrelated to the highly similar micro- 
tubule-binding domains of MAP2  and tau,  although like 
those domains, it has a net positive charge and contains re- 
peated elements. Thus, in common with MAP2 and tau (44, 
45) MAP1B probably interacts ionically with the negatively 
charged carboxyterminal portion of c~-  and/or B-tubulin, 
though it has not been shown whether these molecules com- 
pete for the identical site on microtubules. The binding of 
MAP1B to microtubules is weak compared with MAP2, and 
unlike MAP2 (S.  A.  Lewis, I.  E. Ivanov,  G.-H.  Lee, and 
N. J. Cowan, manuscript submitted for publication) expres- 
sion of high levels of MAPIB in cultured cells does not result 
in any obvious cytoskeletal changes (Fig. 7, a and b). How- 
ever,  MAP1B has two light chains that also associate with 
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teins may alter the properties  of MAP1B. 
The data presented  here for MAP1B,  together  with that 
reported previously for MAP2 and tau (19, 20, 24, 30) and 
for kinesin (53), define three structurally unrelated kinds of 
microtubule binding domains. These differences must in some 
way reflect the different functions served by the interaction 
of each MAP with microtubules. For example, kinesin, which 
acts as a motor for anterograde transport along microtubules 
(8, 48), would be expected to have completely different bind- 
ing properties  from MAP2, which crosslinks and stabilizes 
microtubules in dendrites (S. A. Lewis, I. E. Ivanov, G.-H. 
lee,  and N.  J.  Cowan, manuscript  submitted  for publica- 
tion). Therefore,  it is not surprising  that their binding do- 
mains are completely dissimilar.  It seems probable that each 
of these three binding domains is representative of a separate 
family of functionally related  microtubule-associated  pro- 
teins. 
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